hornblower
Madmaxista
- Desde
- 5 Dic 2009
- Mensajes
- 1.756
- Reputación
- 5.293
Kaxkamel, con todo el respeto pero quizás el que lo desconocía eras tú.desconocian todo de velocidad de contagio, de grado de contagio, de tratamientos, etc... y 3340 muertos en un pais de 1.300 millones.
La OMS en enero conocía perfectamente cómo era el bichito. te copipego parte de un artículo que tenía guardado. Conocían periodo de incubación, que se puede transmitir por aerosol, etc etc.
Clinical presentation: The incubation period is thought to be 2 to 14 days↗. Symptoms include fever (which may be absent in persons at extremes of age or with immunocompromise), cough and dyspnea. Chest radiographs may show bilateral infiltrates. Clinical illness varies from mild to severe; about 25% of confirmed cases have been classified as severe, and there are increasing numbers of deaths↗. In early cases, mortality was associated with advanced age or comorbidities.
Diagnosis: Although respiratory infections (including influenza) are prevalent in the northern hemisphere during the winter, clinicians should inquire about travel history in persons presenting with respiratory illness. The possibility of 2019-nCoV infection should be suspected in persons who present with compatible clinical illness and exposure history. The US Centers for Disease Control (CDC)↗ and World Health Organization (WHO) have slightly different criteria for whom to test, as noted below:
If a patient with suspected 2019-nCoV infection tests positive for another respiratory pathogen, after clinical evaluation and consultation with public health authorities, they may no longer be considered a person under investigation.
Management: No specific antiviral agent is available for treatment of this infection, and there is no vaccine. Treatment is supportive and includes supplemental oxygen and conservative fluid management↗, as indicated by clinical condition. WHO provides detailed guidance on such supportive measures and cautions↗ that severely ill patients should be treated empirically for other possible causes while diagnostic test results are pending.
Infection control measures↗ are an integral part of management. Precautions should be instituted as soon as 2019-nCoV infection is suspected↗:
Diagnosis: Although respiratory infections (including influenza) are prevalent in the northern hemisphere during the winter, clinicians should inquire about travel history in persons presenting with respiratory illness. The possibility of 2019-nCoV infection should be suspected in persons who present with compatible clinical illness and exposure history. The US Centers for Disease Control (CDC)↗ and World Health Organization (WHO) have slightly different criteria for whom to test, as noted below:
- •Recent travel (within 14 days) from Wuhan, Hubei Province, China (WHO, CDC).
- •Close contact with a person suspected or known to have infection due to 2019-nCoV (WHO, CDC). The CDC defines close contact as being within 6 feet (2 meters) or within a room or care area for a prolonged period without personal protective equipment OR having direct contact with secretions of a person with 2019-nCoV infection.
- •Exposure to a healthcare facility in a country where hospital-associated nCoV infections have been reported (WHO).
- •The disease occurs in a healthcare worker who has been working in an environment where patients with severe acute respiratory infections are being cared for, without regard to place of residence or history of travel (WHO).
- •The person develops an unusual or unexpected clinical course, especially sudden deterioration despite appropriate treatment, without regard to place of residence or history of travel, even if another etiology has been identified that fully explains the clinical presentation (WHO).
If a patient with suspected 2019-nCoV infection tests positive for another respiratory pathogen, after clinical evaluation and consultation with public health authorities, they may no longer be considered a person under investigation.
Management: No specific antiviral agent is available for treatment of this infection, and there is no vaccine. Treatment is supportive and includes supplemental oxygen and conservative fluid management↗, as indicated by clinical condition. WHO provides detailed guidance on such supportive measures and cautions↗ that severely ill patients should be treated empirically for other possible causes while diagnostic test results are pending.
Infection control measures↗ are an integral part of management. Precautions should be instituted as soon as 2019-nCoV infection is suspected↗:
- •Provide the patient with a face mask and place the patient in a closed room (preferably with structural safeguards against airborne transmission).
- •Persons entering the room should ***ow standard, contact, and airborne precautions↗.
- •Patients managed at home are encouraged to self-isolate to a single area of the house (preferably with a separate bathroom) and to wear a face mask during any contact with household members.
- •The patient and all household members should ***ow diligent hand and cough hygiene↗.